细菌细菌的表面显示技术:生物处理和可持续制造中的应用
Howra Bahrulolum1, Gholamreza Ahmadian2,2
1Department of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.
Biotechnology for biofuels and bioproducts
|March 16, 2025
概括
细菌细菌表面显示为绿色技术和生物医学应用提供了一个多功能,可持续的平台. 这项技术利用子和植物细胞进行酶固定,生物催化,生物传感器和疫苗开发.
科学领域:
- 生物技术是生物技术.
- 微生物工程 微生物工程
背景情况:
- 在生物加工,医疗保健和制造业中,对可持续和环保解决方案的需求日益增加.
- 细菌细菌的表面显示技术提供了使用子和植物细胞形式的多功能平台.
研究的目的:
- 探索Bacillus subtilis表面显示技术的进步,挑战和机遇.
- 突出其在可持续生物制造,绿色创新和生物医学应用中的作用.
主要方法:
- 利用Bacillus subtilis子和植物性细胞表面显示.
- 在酶固定化,生物催化和生物传感器开发中的应用.
- 利用系统开发疫苗和向药物输送.
主要成果:
- 在生物修复,污染物降解和可再生能源发电方面证明了效率.
- 展示了具有成本效益,可扩展和可持续的疫苗和药物输送系统的潜力.
- 启用针对性传递抗原和治疗分子,以获得强大的免疫反应.
结论:
- 细菌细菌表面显示是一种有前途的技术,用于应对环境可持续性和医疗保健方面的全球挑战.
- 它的多功能性支持从绿色化学到先进治疗的各种应用.
- 进一步的研究可以释放其在可持续生物制造和医学方面的全部潜力.
相关概念视频
Bioreactor Design and Operational System
220
Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...
220
Bioreactor Controls-III
70
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
70
Scale-Up Processes
119
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
119
Upstream Processing
102
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
102
Production of Pharmaceuticals
99
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
99
Production of Biopesticides
120
Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...
120


